# Stem Cell Implantation in Patients Undergoing CABG

> **NCT01721902** · PHASE1 · TERMINATED · sponsor: **Miltenyi Biotec, Inc.** · enrollment: 23 (estimated)

## Conditions studied

- Ischemic Cardiomyopathy
- Coronary Artery Disease

## Interventions

- **DEVICE:** Autologous CD133+ Bone Marrow Stem Cells
- **OTHER:** Carrier Solution

## Key facts

- **NCT ID:** NCT01721902
- **Lead sponsor:** Miltenyi Biotec, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-01
- **Primary completion:** 2013-10
- **Final completion:** 2013-12
- **Target enrollment:** 23 (ESTIMATED)
- **Why stopped:** The study was terminiated due the lack of recruitment.
- **Last updated:** 2013-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01721902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01721902, "Stem Cell Implantation in Patients Undergoing CABG". Retrieved via AI Analytics 2026-09-15 from https://api.ai-analytics.org/clinical/NCT01721902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*